Symposium articlesHereditary breast cancer: clinical features and risk reduction strategies
Under an Elsevier user license
open archive
Cited by (0)
- *
Drs Muggia and Paradiso have reported no financial relationships with companies whose products are mentioned in this supplement. Dr Aapro has received honoraria from Sanofi-Aventis and Novartis.
- *
Drs Muggia and Paradiso have reported no financial relationships with companies whose products are mentioned in this supplement. Dr Aapro has received honoraria from Sanofi-Aventis and Novartis.
- *
Drs Muggia and Paradiso have reported no financial relationships with companies whose products are mentioned in this supplement. Dr Aapro has received honoraria from Sanofi-Aventis and Novartis.
Copyright © 2011 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.